| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aura Biosciences, Inc. | Director | Common Stock | 21,000 | $162,750 | $7.75 | 31 Mar 2025 | Direct |
| Aura Biosciences, Inc. | Director | Stock Option (Right to Buy) | 29,000 | 31 Mar 2025 | Direct | ||
| Fusion Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | 04 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AURA | Aura Biosciences, Inc. | 31 Mar 2025 | 2 | $0 | 4 | Director | 02 Apr 2025, 16:02 |
| AURA | Aura Biosciences, Inc. | 31 Mar 2025 | 0 | $0 | 3 | Director | 02 Apr 2025, 16:01 |
| /report/000095017024068912-bitetti-teresa-marie-2024-06-04 | Fusion Pharmaceuticals Inc. | 04 Jun 2024 | 1 | $0 | 4 | Director | 04 Jun 2024, 17:35 |
| /report/000120919123052878-bitetti-teresa-marie-2023-10-16 | Fusion Pharmaceuticals Inc. | 16 Oct 2023 | 1 | $0 | 4 | Director | 16 Oct 2023, 16:59 |
| /report/000120919123052875-bitetti-teresa-marie-2023-10-16 | Fusion Pharmaceuticals Inc. | 16 Oct 2023 | 0 | $0 | 3 | Director | 16 Oct 2023, 16:56 |